Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality (scientific article published on 19 March 2013)

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration

Q30583563

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy

Q34152118

Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy

Q34416516

CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar

Q35185680

Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy

Q36440576

Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

Q36456745

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

Q37368001

Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients

Q37377683

Stability of hepatitis C virus, HIV, and hepatitis B virus nucleic acids in plasma samples after long-term storage at -20°C and -70°C.

Q38285134

Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.

Q38478259

Treatment of Cytomegalovirus Retinitis in Patients with the Acquired Immunodeficiency Syndrome

Q41522175

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy

Q43564797

Value of necropsy in acquired immunodeficiency syndrome

Q43609630

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group

Q43947240

Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.

Q44710483

Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).

Q45722324

Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom

Q45747974

Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression

Q45770221

Clinical relevance of cytomegalovirus viraemia(*,†).

Q54391854

Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007).

Q54483355

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

Q56837785

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

Q57181650

Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy

Q58473814

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

Cytomegalovirus

Q6946

P304

page(s)

147-155

P577

publication date

2013-03-19

P1433

published in

Clinical Infectious Diseases

Q5133764

P1476

title

Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality

P478

volume

Reverse relations

cites work (P2860)

Q40142694	A common anti-cytomegalovirus drug, ganciclovir, inhibits HIV-1 replication in human tissues ex vivo
Q42214530	Assessment of the efficacy and safety of pre-emptive anti-cytomegalovirus (CMV) therapy in HIV-infected patients with CMV viraemia
Q38125299	Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review
Q58692021	CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV
Q27335899	Chest ultrasonography in patients with HIV: a case series and review of the literature
Q38876754	Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.
Q46032365	Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire.
Q35139226	Cytomegalovirus viral load kinetics in patients with HIV/AIDS admitted to a medical intensive care unit: a case for pre-emptive therapy
Q90026325	Cytomegalovirus viremia associated with increased mortality in cryptococcal meningitis in sub-Saharan Africa
Q40217415	Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients
Q41993154	Impaired polyfunctionality of CD8+ T cells in severe sepsis patients with human cytomegalovirus reactivation
Q38177684	Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing
Q28079533	Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection
Q42237322	Prevalence and predictors of cytomegalovirus retinitis in HIV-infected patients with low CD4 lymphocyte counts in Vietnam.
Q35018886	Restoration of CMV-specific-CD4 T cells with ART occurs early and is greater in those with more advanced immunodeficiency
Q90282547	Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy
Q47369032	Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation